Russell Cohen, MD, on Clinical Application of JAK Inhibitors in IBD Patients


Dr Russell Cohen from the University of Chicago discusses the use of janus kinase inhibitors for the treatment of inflammatory bowel disease, a topic in which he presented at IBD Clinical Challenges and Emerging Therapies 2018.

Russell D. Cohen, MD, is a Professor of Medicine in the Department of Medicine, Section of Gastroenterology, at the University of Chicago in Illinois. He is also the Director of the Inflammatory Bowel Disease Center and the Co-Director of the Advanced IBD Fellowship Program at the University of Chicago.

Submit Feedback